YPR123C is annotated as a dubious open reading frame (ORF) in yeast, but experimental evidence suggests its functional role in DNA damage response pathways. Key findings include:
Role in DNA Repair: YPR123C interacts with the RAD9-dependent checkpoint repair pathway, which is critical for resolving DNA damage caused by ionizing radiation (IR) or chemical agents like methyl methanesulfonate (MMS) .
Suppression of BRCA1-Induced Lethality: Deletion of YPR123C suppresses lethality caused by BRCA1 overexpression in yeast, linking it to homologous recombination repair mechanisms .
Sensitivity to Zymocin: Strains lacking YPR123C exhibit heightened sensitivity to zymocin, a toxin from Kluyveromyces lactis, indicating its role in counteracting DNA damage akin to IR .
YPR123C’s involvement in stress response pathways is highlighted by:
Checkpoint Activation: It works synergistically with the CCR4-NOT complex, which regulates mRNA deadenylation and transcription elongation under DNA damage .
Oxidative Stress Response: While not directly linked to acrolein detoxification (a role of Old Yellow Enzymes ), YPR123C deletion strains show compromised recovery from oxidative DNA lesions .
The YPR123C antibody shares structural and functional parallels with other yeast checkpoint antibodies:
Further studies could explore:
YPR123C refers to a specific gene/protein designation in the Saccharomyces cerevisiae (baker's yeast) genome, located on chromosome XVI. The protein encoded by this gene plays significant roles in cellular processes that make it a valuable target for antibody-based research applications. Antibodies against YPR123C are particularly valuable for studying protein-protein interactions, subcellular localization, and functional characterization in yeast molecular biology. Researchers primarily utilize these antibodies in immunoprecipitation, western blotting, and immunofluorescence microscopy to investigate the protein's expression patterns and biological functions .
Understanding YPR123C's role requires consideration of its expression contexts and interaction partners. When developing experimental approaches targeting this protein, researchers should account for its native expression levels, potential post-translational modifications, and structural characteristics that might affect epitope accessibility. Optimizing antibody-based detection methods often requires preliminary expression analysis using techniques like RT-PCR or RNA-seq to establish baseline expression patterns in your experimental system.
YPR123C antibodies can be employed across numerous experimental techniques in molecular and cellular biology. Most commonly, these antibodies are utilized in western blotting for protein expression quantification, immunoprecipitation for protein-protein interaction studies, chromatin immunoprecipitation (ChIP) for DNA-protein interaction analysis, and immunofluorescence or immunohistochemistry for spatial localization studies . Flow cytometry applications are also relevant when studying cell populations with differential YPR123C expression patterns.
For optimal western blotting results, researchers typically use 1:1000 to 1:5000 antibody dilutions depending on the specific antibody's affinity. Immunoprecipitation protocols generally require 2-5 μg of antibody per sample, while immunofluorescence applications typically employ 1:100 to 1:500 dilutions. The choice of detection method (chemiluminescence, fluorescence, colorimetric) should align with your experimental sensitivity requirements and available imaging equipment. When designing multiplexed experiments, consider potential cross-reactivity with other yeast proteins and implement appropriate controls to ensure signal specificity.
Rigorous validation of YPR123C antibody specificity is essential for generating reliable experimental data. A comprehensive validation approach employs multiple complementary methods to confirm target specificity. Primary validation approaches include western blotting using wild-type versus YPR123C knockout/knockdown samples, competitive binding assays with purified recombinant YPR123C protein, and immunoprecipitation followed by mass spectrometry identification .
Researchers should establish a validation protocol that includes:
| Validation Method | Expected Outcome | Potential Pitfalls |
|---|---|---|
| Western blot with YPR123C knockout | No band at expected MW in knockout | Background bands may persist |
| Peptide competition assay | Signal reduction with increasing peptide concentration | Incomplete blocking with peptide |
| Immunoprecipitation + MS | YPR123C identified as major precipitated protein | Co-precipitating proteins may confound results |
| Orthogonal antibody comparison | Consistent detection pattern with antibodies to different epitopes | Epitope-specific differences in accessibility |
| Cross-reactivity testing | No significant signal in non-yeast systems | Some cross-reactivity with highly conserved proteins |
Additionally, researchers should verify antibody performance across different experimental conditions and sample preparation methods to ensure consistent results. Documentation of antibody lot numbers, validation experiments, and optimization parameters should be maintained to support experimental reproducibility .
Incorporating YPR123C antibodies into multiplexed detection systems enables simultaneous analysis of multiple targets, enhancing experimental efficiency and providing contextual data about protein networks. Advanced multiplexing approaches include multi-color immunofluorescence microscopy, mass cytometry (CyTOF), proximity ligation assays, and antibody microarrays. When designing multiplexed experiments, researchers must carefully consider antibody species, isotypes, and fluorophore/reporter selection to minimize cross-reactivity and spectral overlap .
For immunofluorescence multiplexing, sequential staining protocols may be necessary to prevent antibody cross-reactions. This involves complete elution of primary and secondary antibodies between staining rounds using glycine-SDS buffers (pH 2.0) or commercial antibody stripping solutions. Alternatively, tyramide signal amplification (TSA) permits antibody multiplexing from the same host species by covalently depositing fluorophores that remain after antibody elution. Mass cytometry approaches using metal-conjugated antibodies offer higher multiplexing capacity (30+ targets) with minimal signal overlap compared to fluorescence-based methods .
Recent developments in proximity-based detection methods, such as proximity extension assays (PEA) and in situ proximity ligation assays (PLA), provide additional approaches for studying YPR123C interactions with spatial resolution. These techniques utilize oligonucleotide-conjugated antibodies that generate detectable signals only when target proteins are in close proximity, enabling visualization of protein-protein interactions in their native cellular context with high specificity.
Live-cell imaging with YPR123C antibodies presents significant technical challenges that require specialized approaches to maintain cell viability while achieving sufficient signal detection. Traditional antibodies cannot penetrate intact cell membranes, necessitating alternative strategies for live-cell applications. Researchers typically employ three main approaches: cell-permeable mini-antibodies (e.g., nanobodies, scFvs), antibody-based protein tags, or fusion protein expression systems .
For direct visualization of YPR123C in living yeast cells, consider these methodological approaches:
Generating fluorescently-labeled nanobodies against YPR123C, which can penetrate cells when delivered using cell-penetrating peptides or electroporation
Creating fusion constructs where YPR123C is tagged with fluorescent proteins (GFP, mCherry) or self-labeling protein tags (SNAP-tag, HaloTag)
Implementing the split-GFP complementation system where one GFP fragment is fused to YPR123C and the complementary fragment is delivered via cell-permeable peptides
Critical experimental parameters include maintaining appropriate physiological conditions (temperature, pH, media composition), minimizing phototoxicity through reduced laser power and exposure times, and implementing advanced imaging modalities like spinning disk confocal or light sheet microscopy to reduce photobleaching and phototoxicity. Time-resolved experiments should employ acquisition rates that balance temporal resolution against photodamage considerations .
Detecting post-translational modifications (PTMs) of YPR123C requires specialized antibody strategies that recognize both the protein and its specific modifications. Phosphorylation, ubiquitination, sumoylation, acetylation, and glycosylation represent the most commonly studied PTMs, each requiring distinct experimental approaches. Modification-specific antibodies that recognize YPR123C only when modified at specific residues provide the most direct detection method, though these must be rigorously validated for specificity .
A comprehensive PTM analysis workflow typically includes:
| Approach | Methodology | Advantages | Limitations |
|---|---|---|---|
| Phospho-specific antibodies | Western blot or IP with antibodies recognizing specific phosphorylated residues | Direct detection of specific phosphorylation sites | Limited commercial availability for YPR123C |
| Phospho-enrichment + MS | IP with YPR123C antibody followed by phosphopeptide enrichment and MS analysis | Comprehensive phosphosite mapping | Requires specialized equipment and expertise |
| Ubiquitination detection | IP under denaturing conditions with YPR123C antibody followed by ubiquitin detection | Prevents deubiquitination during sample preparation | May not preserve some labile modifications |
| SUMO-trap pulldown | Tandem purification using YPR123C antibody and SUMO-interaction motifs | Enriches for sumoylated forms | Higher background than site-specific approaches |
| Glycosylation analysis | Lectin affinity purification followed by YPR123C detection | Enriches for specific glycan structures | Lacks residue-specific information |
For advanced applications, researchers can implement proximity-dependent labeling methods (BioID, APEX) by fusing these enzymes to YPR123C to identify proteins spatially associated with the modified forms of YPR123C. This approach provides contextual information about the cellular environment surrounding the modified protein forms .
Effective sample preparation is critical for maximizing YPR123C antibody performance in yeast systems. The rigid cell wall of Saccharomyces cerevisiae presents a significant barrier to antibody accessibility, requiring optimization of cell disruption and protein extraction methods. Researchers should consider both the subcellular localization of YPR123C and its potential interactions when selecting extraction conditions .
For western blotting and immunoprecipitation applications, mechanical disruption methods (glass bead beating, French press) combined with appropriate buffer systems yield optimal results. A standard extraction buffer composition includes: 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1% Triton X-100, 0.1% SDS, 1 mM EDTA, supplemented with protease inhibitors (1 mM PMSF, 5 μg/ml leupeptin, 5 μg/ml pepstatin A, and 5 μg/ml aprotinin). For phospho-specific applications, include phosphatase inhibitors (10 mM NaF, 1 mM Na₃VO₄, 1 mM β-glycerophosphate) .
For immunofluorescence microscopy, spheroplasting protocols using enzymatic digestion (zymolyase or lyticase) effectively remove the cell wall while preserving cellular architecture. A typical spheroplasting buffer consists of 1.2 M sorbitol, 0.1 M potassium phosphate (pH 7.4), 5 mM MgCl₂, and 1 mg/ml zymolyase-20T incubated at 30°C for 20-30 minutes. Following spheroplasting, samples should be fixed with 4% paraformaldehyde and permeabilized with 0.2% Triton X-100 before antibody incubation .
Quantitative analysis of YPR123C antibody signals requires rigorous standardization and appropriate controls to generate reliable data. The analytical approach differs based on the experimental technique, with western blotting, immunofluorescence, and flow cytometry each requiring specific quantification methodologies .
For western blot quantification:
Implement standard curves using purified recombinant YPR123C protein to establish the linear detection range
Normalize YPR123C signals to appropriate loading controls (e.g., PGK1, TDH3 for yeast samples)
Employ digital image analysis software (ImageJ, ImageLab) with background subtraction
Include biological and technical replicates (minimum n=3) for statistical validation
Report results as fold-change relative to a reference condition rather than absolute values
For immunofluorescence quantification, consider both signal intensity and subcellular distribution patterns. Automated high-content imaging platforms with machine learning-based segmentation algorithms improve objectivity and throughput for complex localization patterns. When quantifying colocalization with other markers, implement appropriate statistical measures (Pearson's correlation coefficient, Manders' overlap coefficient) and randomization controls to establish significance thresholds .
Flow cytometry quantification should utilize appropriate fluorescence minus one (FMO) controls, isotype controls, and standardized particles (quantibrite beads) to convert arbitrary fluorescence units to antibody binding capacity when absolute quantification is required. Report population statistics (median fluorescence intensity rather than mean) to account for non-normal distribution patterns typical in biological systems .
Establishing robust reference standards for YPR123C antibody experiments is essential for data reproducibility and inter-laboratory comparisons. A comprehensive reference framework includes both positive and negative controls, calibration standards, and procedural validation metrics .
Essential reference standards include:
| Reference Standard Type | Implementation | Purpose |
|---|---|---|
| Positive control | Wild-type yeast expressing YPR123C | Confirms antibody functionality |
| Negative control | YPR123C knockout strain | Establishes background signal level |
| Overexpression control | Yeast strain with inducible YPR123C | Confirms signal proportionality to expression |
| Tagged control | YPR123C-epitope tag fusion (HA, FLAG) | Enables parallel detection with validated antibodies |
| Purified protein | Recombinant YPR123C protein | Permits absolute quantification and competition assays |
| Dynamic range control | Dilution series of positive control | Establishes linear detection range |
| Technical control | Duplicate/triplicate processing | Assesses procedural variability |
For longitudinal studies, researchers should implement spike-in normalization with stable reference proteins or synthetic peptides to account for batch effects in sample processing and detection. Reporting antibody lot numbers, incubation conditions, and image acquisition parameters is essential for experimental reproducibility. Consider implementing digital barcoding or unique molecular identifiers when working with highly multiplexed detection systems to account for technical variability .
Optimizing signal-to-noise ratio (SNR) in YPR123C antibody experiments requires systematic evaluation of multiple parameters affecting both specific signal generation and background reduction. Researchers should implement a structured optimization approach that addresses antibody concentration, buffer composition, incubation conditions, and detection system parameters .
For western blotting applications, consider this optimization matrix:
| Parameter | Starting Point | Optimization Range | Evaluation Metric |
|---|---|---|---|
| Antibody concentration | 1:1000 dilution | 1:500 to 1:5000 | Signal intensity vs. background |
| Blocking agent | 5% non-fat milk | Milk (1-5%), BSA (1-5%), commercial blockers | Background reduction |
| Primary antibody incubation | Overnight at 4°C | 1 hr at RT to overnight at 4°C | Signal strength and specificity |
| Wash buffer | TBST (0.1% Tween-20) | Tween-20 (0.05-0.3%), Triton X-100 (0.05-0.2%) | Background reduction without signal loss |
| Secondary antibody | 1:5000 HRP-conjugate | 1:2000 to 1:10000, HRP/AP/fluorescent | Detection sensitivity |
| Detection method | ECL | Standard ECL, ECL+, fluorescent, colorimetric | Signal duration and dynamic range |
For immunofluorescence applications, additional considerations include:
Autofluorescence reduction through sodium borohydride treatment (1 mg/ml, 10 min) or commercial quenching agents
Optimization of fixation conditions (formaldehyde concentration 2-4%, methanol vs. paraformaldehyde)
Implementation of signal amplification systems (tyramide signal amplification, quantum dots)
Use of advanced microscopy techniques (structured illumination, confocal, deconvolution) to improve signal discrimination
Document all optimization steps systematically, ideally using a factorial experimental design that can identify interaction effects between parameters. Final protocols should be validated across multiple sample types and experimental conditions to ensure robustness .
Epitope masking occurs when YPR123C protein interactions or conformational states prevent antibody access to its target epitope, resulting in false-negative results. This is particularly problematic when studying proteins in complex interaction networks or specific functional states. Several methodological approaches can address this challenge in different experimental contexts .
Effective epitope unmasking strategies include:
Epitope retrieval techniques: For fixed samples, heat-induced epitope retrieval (HIER) using citrate buffer (pH 6.0) or Tris-EDTA buffer (pH 9.0) at 95°C for 20 minutes can disrupt protein crosslinks that mask epitopes. For particularly resistant samples, protease-induced epitope retrieval using proteinase K or trypsin at controlled concentrations and incubation times can expose additional epitopes.
Denaturing conditions: Implementing strong denaturing conditions (8M urea, 6M guanidine hydrochloride) during protein extraction disrupts protein-protein interactions that may mask epitopes. For western blotting, stronger detergents (1% SDS) and reducing agents (100 mM DTT) effectively expose epitopes that are masked in native conditions.
Multiple antibody approach: Utilizing antibodies targeted to different epitopes on YPR123C increases detection probability regardless of interaction partners. Create an antibody panel targeting N-terminal, C-terminal, and internal epitopes to comprehensively detect YPR123C under various conditions.
Proximity-based labeling: When studying YPR123C in intact complexes, implement proximity labeling approaches (BioID, APEX) that tag nearby proteins regardless of epitope accessibility, followed by stringent purification and detection methods.
For cases where direct antibody access remains challenging, consider alternative protein detection approaches such as genetic tagging with split reporter systems or MS-based proteomic identification rather than antibody-based detection .
Cross-reactivity assessment is essential for validating antibody specificity and preventing misinterpretation of experimental results. A comprehensive cross-reactivity analysis for YPR123C antibodies should evaluate potential binding to related proteins, common contaminants, and non-specific interactions with experimental components .
Implement this systematic cross-reactivity assessment workflow:
Computational analysis: Perform sequence alignment of the immunizing antigen or epitope against the entire yeast proteome to identify proteins with similar epitopes. Pay particular attention to proteins in the same family or with conserved domains.
Knockout validation: Test antibody against YPR123C knockout samples, which should show complete absence of specific signal if the antibody is truly specific. CRISPR/Cas9 or traditional gene deletion approaches in yeast provide appropriate negative controls.
Overexpression assessment: Evaluate signal intensity correlation with controlled overexpression levels of YPR123C. Linear signal increase with expression level supports specificity.
Epitope competition: Pre-incubate antibody with excess purified antigen or immunizing peptide before sample application. Specific signals should be competitively inhibited while cross-reactive signals may remain.
Orthogonal detection: Compare detection patterns using antibodies against different epitopes of YPR123C or tagged versions detected with tag-specific antibodies.
To mitigate identified cross-reactivity:
Implement affinity purification of antibodies using immobilized YPR123C protein to enrich for specific antibodies
Pre-absorb antibody preparations against fixed and permeabilized YPR123C knockout cells to remove cross-reactive antibodies
Optimize assay conditions (higher stringency washes, alternative detergents, blocking agents) to reduce non-specific binding
Consider using competitive elution from immunoprecipitates with excess antigen to preferentially recover specific interactions